Literature DB >> 17602370

Cervical ultrasound (US) and US-guided lymph node biopsy as a routine procedure for staging of lung cancer.

H Prosch1, G Strasser, C Sonka, E Oschatz, S Mashaal, A Mohn-Staudner, G H Mostbeck.   

Abstract

PURPOSE: To assess the value of routine ultrasound evaluation and US-guided fine-needle aspiration biopsy of supraclavicular lymph nodes for the diagnosis, staging and treatment of patients with lung cancer.
MATERIALS AND METHODS: 300 consecutive patients with lung cancer were evaluated with high-resolution ultrasound for the presence of pathological lymph nodes (criteria: short-axis >or= 5 mm, rounded shape, missing echogenic hilum). Suspicious lymph nodes were biopsied under ultrasound guidance if the result could influence further patient management
RESULTS: In 41 of 257 NSCLC patients (16 %) and 15 of 43 (35 %) SCLC patients, enlarged lymph nodes were detected, in particular in patients with a CT stage N2 or N3 (NSCLC) or extensive disease (SCLC). 16 lymph node biopsies were positive for malignancy, 4 biopsies were negative for malignancy or not diagnostic. US had a higher sensitivity for the detection of pathological lymph nodes than CT.
CONCLUSION: Routine ultrasound evaluation of supraclavicular lymph nodes reveals suspicious lymph nodes in a high number of patients with lung cancer. High-resolution US is superior to CT in the detection of pathological lymph nodes. Ultrasound-guided biopsy proves malignancy and thereby a N3 or M1 stage. Thus, more invasive and expensive diagnostic procedures can be avoided.

Entities:  

Mesh:

Year:  2007        PMID: 17602370     DOI: 10.1055/s-2007-963215

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  7 in total

1.  Emerging roles for transthoracic ultrasonography in pulmonary diseases.

Authors:  Sergio Sartori; Paola Tombesi
Journal:  World J Radiol       Date:  2010-06-28

Review 2.  Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.

Authors:  Christoph Frank Dietrich; Jouke Tabe Annema; Paul Clementsen; Xin Wu Cui; Mathias Maximilian Borst; Christian Jenssen
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

Review 3.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

4.  [Oncologic imaging: indications for and limitations of modern cross-sectional imaging techniques].

Authors:  M E Mayerhoefer; A Ba-Ssalamah; H Prosch
Journal:  Radiologe       Date:  2013-04       Impact factor: 0.635

5.  The value of ultrasound-guided biopsy of fluorodeoxy-glucose positron emission tomography (FDG-PET)-positive supraclavicular lymph nodes in patients with suspected lung cancer.

Authors:  Lennart Werner; Franziska Aebersold Keller; Ujwal Bhure; Justus Egidius Roos; Katharina Tornquist; Maria Del Sol Pèrez-Lago; Oliver Gautschi; Klaus Strobel
Journal:  BMC Med Imaging       Date:  2017-07-11       Impact factor: 1.930

6.  Lung cancer imaging methods in China from 2005 to 2014: A national, multicenter study.

Authors:  Dong-Hui Hou; Shi-Jun Zhao; Ju-Fang Shi; Le Wang; De-Bin Wang; Yun-Chao Huang; Xian-Zhen Liao; Xiao-Jing Xing; Ling-Bin Du; Li Yang; Yu-Qin Liu; Yong-Zhen Zhang; Dong-Hua Wei; Yun-Yong Liu; Kai Zhang; Ni Li; Wan-Qing Chen; You-Lin Qiao; Jie He; Min Dai; Ning Wu
Journal:  Thorac Cancer       Date:  2019-02-08       Impact factor: 3.500

7.  Performance of Ultrasound-Guided Core Biopsy Driven by FDG-avid Supraclavicular Lymph Nodes in Patients With Suspected Lung Cancer.

Authors:  Tongtong Wang; Junbao Liu; Ningning Lv; Shi Xuan; Lin Bai; Bin Ji; Shi Gao
Journal:  Front Med (Lausanne)       Date:  2022-01-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.